Matucci-Cerinic M - Search Results

1

Mechanisms of vascular damage in SSc--implications for vascular treatment strategies.

Guiducci S, Distler O, Distler JH, Matucci-Cerinic M. Guiducci S, et al. Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v18-20. doi: 10.1093/rheumatology/ken267. Rheumatology (Oxford). 2008. PMID: 18784130 Free article. Review.

2

Pregnancy in systemic sclerosis.

Miniati I, Guiducci S, Mecacci F, Mello G, Matucci-Cerinic M. Miniati I, et al. Rheumatology (Oxford). 2008 Jun;47 Suppl 3:iii16-8. doi: 10.1093/rheumatology/ken174. Rheumatology (Oxford). 2008. PMID: 18504278 Review.

3

Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.

Del Rosso A, Distler O, Milia AF, Emanueli C, Ibba-Manneschi L, Guiducci S, Conforti ML, Generini S, Pignone A, Gay S, Madeddu P, Matucci-Cerinic M. Del Rosso A, et al. Ann Rheum Dis. 2005 Mar;64(3):382-7. doi: 10.1136/ard.2004.023382. Ann Rheum Dis. 2005. PMID: 15708892 Free PMC article.

4

Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.

Del Rosso A, Cinelli M, Guiducci S, Pignone A, Fibbi G, Margheri F, Gabrielli A, Giacomelli R, Coppini A, Del Rosso M, Matucci Cerinic M. Del Rosso A, et al. Rheumatology (Oxford). 2005 Oct;44(10):1255-62. doi: 10.1093/rheumatology/kei006. Epub 2005 Jul 5. Rheumatology (Oxford). 2005. PMID: 15998634

5

Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis.

Kaloudi O, Basta G, Perfetto F, Bartoli F, Del Rosso A, Miniati I, Conforti ML, Generini S, Guiducci S, Abbate R, Pignone A, Castellani S, Livi R, De Caterina R, Matucci-Cerinic M. Kaloudi O, et al. Rheumatology (Oxford). 2007 Mar;46(3):412-6. doi: 10.1093/rheumatology/kel076. Epub 2006 Aug 27. Rheumatology (Oxford). 2007. PMID: 16936331

6

Etrurians vs Greeks: May ACE I/D polymorphism still be considered as a marker of susceptibility to SSc?

Guiducci S, Fatini C, Georgountzos A, Sticchi E, Cinelli M, Kaloudi O, Rogai V, Melchiorre D, Pignone A, Vlachoyannopoulos P, Abbate R, Matucci Cerinic M. Guiducci S, et al. Clin Exp Rheumatol. 2006 Jul-Aug;24(4):432-4. Clin Exp Rheumatol. 2006. PMID: 16956435

7

Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes.

Cinelli M, Guiducci S, Del Rosso A, Pignone A, Del Rosso M, Fibbi G, Serratì S, Gabrielli A, Giacomelli R, Piccardi N, Matucci Cerinic M. Cinelli M, et al. Scand J Rheumatol. 2006 Sep-Oct;35(5):346-50. doi: 10.1080/03009740600709865. Scand J Rheumatol. 2006. PMID: 17062432

8

Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis.

Bartoli F, Angotti C, Fatini C, Conforti ML, Guiducci S, Blagojevic J, Melchiorre D, Fiori G, Generini S, Damjanov N, Rednic S, Pignone A, Castellani S, Abbate R, Matucci Cerinic M. Bartoli F, et al. Rheumatology (Oxford). 2007 May;46(5):772-5. doi: 10.1093/rheumatology/kel433. Epub 2007 Jan 30. Rheumatology (Oxford). 2007. PMID: 17264090

9

A path to the future in scleroderma.

Distler O, Matucci-Cerinic M, Müller-Ladner U, Seibold JR. Distler O, et al. Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v1. doi: 10.1093/rheumatology/ken351. Rheumatology (Oxford). 2008. PMID: 18784125 Free article. No abstract available.

10

Animal models in systemic sclerosis.

Rogai V, Lories RJ, Guiducci S, Luyten FP, Matucci Cerinic M. Rogai V, et al. Clin Exp Rheumatol. 2008 Sep-Oct;26(5):941-6. Clin Exp Rheumatol. 2008. PMID: 19032835 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

893 results

Search Page